ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Human Influenza
Pneumonia
Respiratory Tract Infections
Virus Diseases

COVID-19 trials near San Francisco, CA, USA:

Recently updated

Imaging Immune Activation in COVID-19

by whole-body PET-CT imaging in participants with convalescent COVID-19. Up to 80 participants will be enrolled over an accrual per...

Enrolling
Covid19
SARS-CoV Infection
Drug: [18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine)

Phase 2

CellSight Technologies

San Francisco, California, United States

The purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19, ca-...

Active, not recruiting
COVID-19
SARS-COV-2 Infection
Biological: BNT162b2 (2025/2026 formulation)

Phase 3

BioNTech
BioNTech

Palo Alto, California, United States and 30 other locations

Status recently updated

This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19...

Not yet enrolling
Active, not recruiting
COVID-19
Sars-CoV-2 Infection
Biological: NVX-CoV2705
Biological: Placebo

Phase 4

Novavax
Novavax

Walnut Creek, Colorado, United States of America and 98 other locations

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...

Enrolling
Coronavirus Disease (COVID-19)
Drug: Placebo
Drug: Molnupiravir

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

San Francisco, California, United States and 221 other locations

The purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19.Thi-...

Active, not recruiting
COVID-19
SARS-COV-2 Infection
Biological: BNT162b2 (2025/2026 recommended SARS-CoV-2 strain)

Phase 3

BioNTech
BioNTech

Walnut Creek, Colorado, United States of America and 18 other locations

studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...

Active, not recruiting
COVID-19
SARS-CoV-2 Virus
Biological: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose
Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 10 microgram dose

Phase 3

BioNTech
BioNTech

Oakland, California, United States and 100 other locations

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health proble-...

Active, not recruiting
COVID-19
SARS-COV-2 Infection
Biological: Placebo
Biological: BNT162b2 Vaccine

Phase 3

BioNTech
BioNTech

Walnut Creek, Colorado, United States of America and 199 other locations

This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...

Active, not recruiting
COVID-19
Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
Other: Placebo

Phase 2, Phase 3

Novavax
Novavax

Walnut Creek, California, United States and 94 other locations

There is a pressing need to increase capacity to treat PTSD related to or exacerbated by the COVID-19 pandemic. Texting-based thera...

Active, not recruiting
Posttraumatic Stress Disorder
Behavioral: Reminder as Usual
Behavioral: CPT-Text
Stanford University
Stanford University

Palo Alto, California, United States and 2 other locations

This study will test the safety and tolerability of Anktiva in patients with Long Covid. Eligible patients will receive up to 2 doses of Anktiva and...

Enrolling
Long COVID
Drug: N-803 (IL-15 Superagonist)

Phase 2

ImmunityBio
ImmunityBio

San Francisco, California, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems